Pubblicazioni

AUGMENTed Real-World Data Enhances Comparative Efficacy Between Once-Weekly Insulin Icodec with Dosing Guide App Versus Once-Daily Insulin Glargine U300 in Insulin-Naive Type 2 Diabetes

2025 - DIABETES THERAPY

Billings, Liana K.; Asong, Marisse; BÃ¸g, Martin; Clancy, Simon; Kruse, Christian; de Laguiche, Elisabeth; Maddaloni, Ernesto

Preferences, Expectations and Attitudes on Basal Insulin from PatientâPhysicianâPayer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study)

2025 - DIABETES THERAPY

Fadini, Gian Paolo; Ciardullo, Stefano; Perseghin, Gianluca; Giordano, Carla; Maddaloni, Ernesto; Buzzetti, Raffaella; Ghiani, Mariangela; Avogaro, Angelo

Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the OnsetÂ 9 Trial

2022 - DIABETES THERAPY

Lane, W.; Favaro, E.; Jodar, E.; Kelkar, P.; Oviedo, A.; Sivarathinasami, R.; Senior, P. A.; Sesti, G.; Franek, E.

IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study

2022 - DIABETES THERAPY

Fadini, Gian Paolo; Buzzetti, Raffaella; Fittipaldi, Maria Rosa; D'Incau, Ferruccio; Da Porto, Andrea; Girelli, Angela; Simoni, Lucia; Lastoria, Giusi; Consoli, Agostino

Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents

2019 - DIABETES THERAPY

Gentilella, Raffaella; Romera, Irene; Nicolay, Claudia; Buzzetti, Raffaella; VÃ¡zquez, Luis Alberto; Sesti, Giorgio

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study

2018 - DIABETES THERAPY

Fadini, Gian Paolo; Bottigliengo, Daniele; D'Angelo, Federica; Cavalot, Franco; Bossi, Antonio Carlo; Zatti, Giancarlo; Baldi, Ileana; Avogaro, Angelo; DARWIN-T2D, Network; Buzzetti, Raffaella; Morano, S.